Research
Overview
Latest Research
Gene Therapy Clinical Trial to Start in October for SFN Pain
September 5th, 2025A clinical trial using gene therapy to reduce severe pain from SFN is set to begin in October. If you are in the Boston area, you may be eligible to participate.
From Pain-Centric to Multi-Symptom Small Fiber Neuropathy
August 25th, 2025This study aimed to characterize the symptomatic variability of SFN and determine whether patients can be stratified into meaningful subgroups.
Low Dose Naltrexone Shows Promise for SFN
August 20th, 2025LDN may improve symptoms in cryptogenic SFN, especially sensory and autonomic domains.
Peripheral Neuropathy in POTS: GI Symptom Links
July 3rd, 2025Study finds small and large fiber neuropathy in Swedish POTS patients, with links to GI symptoms.
FDA Clears ST-503 for Neuropathic Pain Trials
December 14th, 2024FDA clears Sangamo’s ST-503 for Phase I/II trial in idiopathic SFN and chronic neuropathic pain.
Share feedback, ideas, or information corrections in our quick anonymous survey to help improve the SFN Foundation website.
Google Form Survey